Mechanisms of the prostaglandin F2alpha-induced rise in [Ca2+]i in rat intrapulmonary arteries

J Physiol. 2006 Feb 15;571(Pt 1):147-63. doi: 10.1113/jphysiol.2005.101394. Epub 2005 Dec 15.

Abstract

The mechanisms by which prostaglandin F(2alpha) (PGF(2alpha)) increases intracellular Ca2+ concentration [Ca2+]i in vascular smooth muscle remain unclear. We examined the role of store-, receptor- and voltage-operated Ca2+ influx pathways in rat intrapulmonary arteries (IPA) loaded with Fura PE-3. Low concentrations (0.01-1 microM) of PGF(2alpha) caused a transient followed by a plateau rise in [Ca2+]i. Both responses became maximal at 0.1 microM PGF(2alpha). At higher concentrations of PGF(2alpha), a further slower rise in [Ca2+]i was superimposed on the plateau. The [Ca2+]i response to 0.1 microM PGF(2alpha) was mimicked by the FP receptor agonist fluprostenol, whilst the effect of 10 microM PGF(2alpha) was mimicked by the TP receptor agonist U-46619. The plateau rise in [Ca2+]i in response to 0.1 microM PGF(2alpha) was insensitive to diltiazem, and was abolished in Ca2+-free physiological salt solution, and by pretreatment with La3+, 2-APB, thapsigargin or U-73122. The rises in [Ca2+]i in response to 10 microM PGF(2alpha) and 0.01 microM U-46619 were partially inhibited by diltiazem. The diltiazem-resistant components of both of these responses were inhibited by 2-APB and La3+ to an extent which was significantly less than that seen for the response to 0.1 microM PGF(2alpha), and were also much less sensitive to U-73122. The U-46619 response was also relatively insensitive to thapsigargin. When Ca2+ was replaced with Sr2+, the sustained increase in the Fura PE-3 signal to 0.1 microM PGF(2alpha) was abolished, whereas 10 microM PGF(2alpha) and 0.05 microM U-46619 still caused substantial increases. These results suggest that low concentrations of PGF(2alpha) act via FP receptors to cause IP3-dependent Ca2+ release and store operated Ca2+ entry (SOCE). U-46619 and 10-100 microM PGF(2alpha) cause a TP receptor-mediated Ca2+ influx involving both L-type Ca2+ channels and a receptor operated pathway, which differs from SOCE in its susceptibility to La3+, 2-APB and thapsigargin, does not require phospholipase C activation, and is Sr2+ permeable.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Animals
  • Boron Compounds / pharmacology
  • Calcium / analysis*
  • Calcium / metabolism*
  • Calcium Channels, L-Type / physiology
  • Cardiovascular Agents / pharmacology
  • Diltiazem / pharmacology
  • Dinoprost / pharmacology*
  • Inositol 1,4,5-Trisphosphate / physiology
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology
  • Pulmonary Artery / chemistry
  • Pulmonary Artery / metabolism*
  • Rats
  • Rats, Wistar
  • Receptors, Prostaglandin / drug effects
  • Receptors, Prostaglandin / physiology
  • Receptors, Thromboxane / drug effects
  • Receptors, Thromboxane / physiology
  • Signal Transduction / physiology
  • Type C Phospholipases / pharmacology
  • Vasoconstriction / drug effects
  • Vasoconstrictor Agents / pharmacology

Substances

  • Boron Compounds
  • Calcium Channels, L-Type
  • Cardiovascular Agents
  • Receptors, Prostaglandin
  • Receptors, Thromboxane
  • Vasoconstrictor Agents
  • prostaglandin F2alpha receptor
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Inositol 1,4,5-Trisphosphate
  • Dinoprost
  • 2-aminoethoxydiphenyl borate
  • Type C Phospholipases
  • Diltiazem
  • Calcium